Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin recepto…

Biotechnology

US, Seattle [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Chinook Therapeutics, Inc. to fulfill lobbying activities in the US.

Chinook Therapeutics, Inc. has no lobbying expenses in our database.

History

Download

FY	Quarter	Expense For Lobby Disclosure	LDA Reference
No data